Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion

Franklin C. Lowe, J. Batista, R. Berges, E. Chartier-Kastler, G. Conti, F. Desgrandchamps, K. Dreikorn, M. O'Leary, M. Perez, M. Speakman, J. Trachtenberg, A. Tubaro, B. Meesen, L. Smets, H. Stoevelaar

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalProstate Cancer and Prostatic Diseases
Volume8
Issue number3
DOIs
StatePublished - Sep 2005
Externally publishedYes

Fingerprint

Lower Urinary Tract Symptoms
Expert Testimony
Prostatic Hyperplasia
Disease Progression

Keywords

  • Benign prostatic hyperplasia
  • Disease progression
  • Lower urinary tract symptoms
  • Risk factors

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) : A systematic analysis of expert opinion. / Lowe, Franklin C.; Batista, J.; Berges, R.; Chartier-Kastler, E.; Conti, G.; Desgrandchamps, F.; Dreikorn, K.; O'Leary, M.; Perez, M.; Speakman, M.; Trachtenberg, J.; Tubaro, A.; Meesen, B.; Smets, L.; Stoevelaar, H.

In: Prostate Cancer and Prostatic Diseases, Vol. 8, No. 3, 09.2005, p. 206-209.

Research output: Contribution to journalArticle

Lowe, FC, Batista, J, Berges, R, Chartier-Kastler, E, Conti, G, Desgrandchamps, F, Dreikorn, K, O'Leary, M, Perez, M, Speakman, M, Trachtenberg, J, Tubaro, A, Meesen, B, Smets, L & Stoevelaar, H 2005, 'Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion', Prostate Cancer and Prostatic Diseases, vol. 8, no. 3, pp. 206-209. https://doi.org/10.1038/sj.pcan.4500806
Lowe, Franklin C. ; Batista, J. ; Berges, R. ; Chartier-Kastler, E. ; Conti, G. ; Desgrandchamps, F. ; Dreikorn, K. ; O'Leary, M. ; Perez, M. ; Speakman, M. ; Trachtenberg, J. ; Tubaro, A. ; Meesen, B. ; Smets, L. ; Stoevelaar, H. / Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) : A systematic analysis of expert opinion. In: Prostate Cancer and Prostatic Diseases. 2005 ; Vol. 8, No. 3. pp. 206-209.
@article{54c18fd7de7446eea0762c08b5ecbbd5,
title = "Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion",
abstract = "Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.",
keywords = "Benign prostatic hyperplasia, Disease progression, Lower urinary tract symptoms, Risk factors",
author = "Lowe, {Franklin C.} and J. Batista and R. Berges and E. Chartier-Kastler and G. Conti and F. Desgrandchamps and K. Dreikorn and M. O'Leary and M. Perez and M. Speakman and J. Trachtenberg and A. Tubaro and B. Meesen and L. Smets and H. Stoevelaar",
year = "2005",
month = "9",
doi = "10.1038/sj.pcan.4500806",
language = "English (US)",
volume = "8",
pages = "206--209",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH)

T2 - A systematic analysis of expert opinion

AU - Lowe, Franklin C.

AU - Batista, J.

AU - Berges, R.

AU - Chartier-Kastler, E.

AU - Conti, G.

AU - Desgrandchamps, F.

AU - Dreikorn, K.

AU - O'Leary, M.

AU - Perez, M.

AU - Speakman, M.

AU - Trachtenberg, J.

AU - Tubaro, A.

AU - Meesen, B.

AU - Smets, L.

AU - Stoevelaar, H.

PY - 2005/9

Y1 - 2005/9

N2 - Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

AB - Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

KW - Benign prostatic hyperplasia

KW - Disease progression

KW - Lower urinary tract symptoms

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=29944438602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29944438602&partnerID=8YFLogxK

U2 - 10.1038/sj.pcan.4500806

DO - 10.1038/sj.pcan.4500806

M3 - Article

C2 - 15953934

AN - SCOPUS:29944438602

VL - 8

SP - 206

EP - 209

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 3

ER -